Product Safety Recalls

Product Recall Tracker

SOLIFENACIN SUCCINATE Recall D-0333-2025

Description: Solifenacin Succinate Tablets 5mg, a.) 30-count bottle (NDC# 68462-386-30) b.) 90-count bottle (NDC# 68462-386-90), Rx Only. Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430.

SOLIFENACIN SUCCINATE Recall D-0333-2025 Information

StatusOngoing
Mandated?Voluntary: Firm initiated
Recall NumberD-0333-2025
Event ID96474
BrandSOLIFENACIN SUCCINATE
Generic NameSOLIFENACIN SUCCINATE
ManufacturerSOLIFENACIN SUCCINATE
Original Package?1
Active SubstanceSOLIFENACIN SUCCINATE
Drug RouteORAL
DistributionU.S. Nationwide
QuantityN/A
Recall ReasonCGMP Deviations
Drug ClassificationClass II
Drug Code Info20250416
Product NDC68462-386 68462-387
Drug UPC0368462386309 0368462387306
Recall Initiation Date20250313
Report Date20250416
Classification Date20250408
Address750 Corporate DrN/A
Mahwah, NJ 07430-2009
United States
Recalling FirmGlenmark Pharmaceuticals Inc., USA
Initial Notification Letter
Unique Ingredient IdentifierKKA5DLD701
Drug Application NumberANDA209239
Structured Product Labeling (SPL ID)9cfcab1d-64ac-457b-979f-41cf6547a63a
Structured Product Labeling (SPL Set ID)010c0657-c907-477f-8bd7-5d455a5f50eb
Similar To

© 2022 Recall.Report / Contact / Privacy Policy

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied.
Recall.report is not affiliated with the Consumer Product Safety Commision, FDA, or US government in any way.